BACKGROUND: Obesity places surgical patients at a greater risk of complications. The effects of obesity on outcomes and complications from percutaneous nephrolithotomy (PCNL) are not well defined. OBJECTIVE: The objective of this study was to stratify outcome and morbidity of PCNL with respect to body mass index (BMI) in a large contemporary series. METHODS: The charts of 234 patients who underwent PCNL were reviewed retrospectively. Patients were divided into four groups depending on their BMIs: ideal body weight (IBW) <25 kg/m(2), overweight 25 to 29.9 kg/m(2), obese >or=30 to 34.9 kg/m(2), and morbidly obese >or=35 kg/m(2). Kidney stone diameter was measured on preoperative computerized tomography scans. Hemorrhage was estimated using hematocrit. Univariate analysis was performed with respect to hospital length of stay (HLOS), stone size, complication rate, hemorrhage, and stone-free rate. RESULTS: Of the 234 patients undergoing PCNL (mean age, 54.3 +/- 13.6 years; 54% male), height and weight data were available for 187 (80%) with a mean BMI of 29.3 +/- 8.0 (range 14.1-57.2); 38 (20.3%) were morbidly obese, 43 (23%) obese, 45 (24.1%) overweight, and 61 (32.6%) were within or below their IBW. Mean stone sizes were comparable: 3.9 +/- 2.0 cm (morbidly obese), 3.7 +/- 2.0 cm (obese), 3.1 +/- 1.4 cm (overweight), and 3.6 +/- 1.9 cm (IBW). Mean HLOS (days) was similar between groups: 2.6 +/- 1.7 (morbidly obese), 2.8 +/- 2.0 (obese), 2.5 +/- 1.2 (overweight), and 3.4 +/- 4.7 (IBW). The largest interval decreases in hematocrit (mg/dL) were also comparable: 5.3 +/- 3.8 (morbidly obese), 5.9 +/- 4.3 (obese), 7.2 +/- 4.1 (overweight), and 6.2 +/- 4.3 (IBW). Using strict imaging criteria, the overall stone-free rate was 80%. No statistically significant differences among the three groups were seen with respect to HLOS, stone-free rate, complication rate, or change in hematocrit when stratified by BMI. CONCLUSION: Stone-free rate, complication rate, hemorrhage, and HLOS are independent of BMI in a retrospective review of patients undergoing PCNL.
BACKGROUND:Obesity places surgical patients at a greater risk of complications. The effects of obesity on outcomes and complications from percutaneous nephrolithotomy (PCNL) are not well defined. OBJECTIVE: The objective of this study was to stratify outcome and morbidity of PCNL with respect to body mass index (BMI) in a large contemporary series. METHODS: The charts of 234 patients who underwent PCNL were reviewed retrospectively. Patients were divided into four groups depending on their BMIs: ideal body weight (IBW) <25 kg/m(2), overweight 25 to 29.9 kg/m(2), obese >or=30 to 34.9 kg/m(2), and morbidly obese >or=35 kg/m(2). Kidney stone diameter was measured on preoperative computerized tomography scans. Hemorrhage was estimated using hematocrit. Univariate analysis was performed with respect to hospital length of stay (HLOS), stone size, complication rate, hemorrhage, and stone-free rate. RESULTS: Of the 234 patients undergoing PCNL (mean age, 54.3 +/- 13.6 years; 54% male), height and weight data were available for 187 (80%) with a mean BMI of 29.3 +/- 8.0 (range 14.1-57.2); 38 (20.3%) were morbidly obese, 43 (23%) obese, 45 (24.1%) overweight, and 61 (32.6%) were within or below their IBW. Mean stone sizes were comparable: 3.9 +/- 2.0 cm (morbidly obese), 3.7 +/- 2.0 cm (obese), 3.1 +/- 1.4 cm (overweight), and 3.6 +/- 1.9 cm (IBW). Mean HLOS (days) was similar between groups: 2.6 +/- 1.7 (morbidly obese), 2.8 +/- 2.0 (obese), 2.5 +/- 1.2 (overweight), and 3.4 +/- 4.7 (IBW). The largest interval decreases in hematocrit (mg/dL) were also comparable: 5.3 +/- 3.8 (morbidly obese), 5.9 +/- 4.3 (obese), 7.2 +/- 4.1 (overweight), and 6.2 +/- 4.3 (IBW). Using strict imaging criteria, the overall stone-free rate was 80%. No statistically significant differences among the three groups were seen with respect to HLOS, stone-free rate, complication rate, or change in hematocrit when stratified by BMI. CONCLUSION: Stone-free rate, complication rate, hemorrhage, and HLOS are independent of BMI in a retrospective review of patients undergoing PCNL.
Authors: Namık Kemal Hatipoglu; Mehmet Nuri Bodakci; Necmettin Penbegül; Yaşar Bozkurt; Ahmet Ali Sancaktutar; Murat Atar; Haluk Söylemez Journal: Urolithiasis Date: 2013-04-07 Impact factor: 3.436
Authors: Fabio C M Torricelli; Guilherme P Padovani; Giovanni S Marchini; Fabio C Vicentini; Alexandre Danilovic; Sabrina T Reis; Miguel Srougi; Eduardo Mazzucchi Journal: Int Braz J Urol Date: 2015 May-Jun Impact factor: 1.541